Loading clinical trials...
Loading clinical trials...
Paraclinical Assessment of Cardiometabolic Risk Based on Novel Biochemical İndices in Type 2 Diabetes
Conditions
Locations
1
Turkey (Türkiye)
Tokat Gaziosmanpaşa University Health Research and Application Hospital
Tokat Province, Turkey (Türkiye)
Start Date
March 1, 2025
Primary Completion Date
November 15, 2025
Completion Date
December 15, 2025
Last Updated
January 23, 2026
NCT05563090
NCT05128747
NCT05107063
Lead Sponsor
Tokat Gaziosmanpasa University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions